Adjuvant Therapy for Cutaneous Melanoma

被引：1
|
作者：
Schuitevoerder, Darryl [1 ]
Vining, Charles C. [1 ]
Tseng, Jennifer [1 ]
机构：
[1] Univ Chicago, Dept Surg, 5841 South Maryland Ave MC5094, Chicago, IL 60637 USA
来源：
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2020年 / 29卷 / 03期
关键词：
Melanoma; Adjuvant therapy; Immunotherapy; Targeted therapy; BRAF; MEK; DABRAFENIB PLUS TRAMETINIB; RANDOMIZED PHASE-III; HIGH-RISK MELANOMA; ADVANCED BRAF(V600)-MUTANT MELANOMA; HIGH-DOSE INTERFERON-ALPHA-2B; COOPERATIVE-ONCOLOGY-GROUP; LYMPH-NODE DISSECTION; RESECTED STAGE-III; METASTATIC MELANOMA; OPEN-LABEL;
D O I：
10.1016/j.soc.2020.02.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This article presents the current data supporting adjuvant therapy for patients with cutaneous melanoma. With the recent development of novel immunotherapy agents as well as targeted therapy, there are strong data to support the use of these therapies in patients at high risk of developing recurrent or metastatic disease.
引用
收藏
页码：455 / +
页数：12
相关论文
共 50 条
  • [1] Adjuvant Therapy for Melanoma
    Wada-Ohno, Maiko
    Ito, Takamichi
    Furue, Masutaka
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (08)
  • [2] Novel adjuvant options for cutaneous melanoma
    Dimitriou, F.
    Long, G. V.
    Menzies, A. M.
    ANNALS OF ONCOLOGY, 2021, 32 (07) : 854 - 865
  • [3] Cutaneous melanoma
    Rutkowski, Piotr
    Wysocki, Piotr J.
    Nasierowska-Guttmejer, Anna
    Jeziorski, Arkadiusz
    Wysocki, Wojciech M.
    Kalinka, Ewa
    Switaj, Tomasz
    Kozak, Katarzyna
    Kaminska-Winciorek, Grazyna
    Czarnecka, Anna M.
    Kosela-Paterczyk, Hanna
    Wisniewski, Piotr
    Szumera-Cieckiewicz, Anna
    Zdzienicki, Marcin
    Cybulska-Stopa, Bozena
    Ziobro, Marek
    Fijuth, Jacek
    Kawecki, Andrzej
    Rudnicka, Lidia
    Owczarek, Witold
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2020, 16 (04): : 163 - 182
  • [4] Systemic adjuvant therapy for high-risk cutaneous melanoma
    Kobeissi, Iyad
    Tarhini, Ahmad A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [5] Adjuvant and Neoadjuvant Therapeutics for the Treatment of Cutaneous Melanoma
    Bruce, William J.
    Koljonen, Jessie L.
    Romanelli, Michael R.
    Khan, Aziz U.
    Neumeister, Michael W.
    CLINICS IN PLASTIC SURGERY, 2021, 48 (04) : 651 - 658
  • [6] Adjuvant systemic therapy in high-risk melanoma
    Blankenstein, Stephanie A.
    van Akkooi, Alexander C. J.
    MELANOMA RESEARCH, 2019, 29 (04) : 358 - 364
  • [7] Adjuvant Therapy for Melanoma: Past, Current, and Future Developments
    Testori, Alessandro A. E.
    Chiellino, Silvia
    van Akkooi, Alexander C. J.
    CANCERS, 2020, 12 (07) : 1 - 14
  • [8] Considering adjuvant therapy for stage II melanoma
    Poklepovic, Andrew S.
    Luke, Jason J.
    CANCER, 2020, 126 (06) : 1166 - 1174
  • [9] The Evolution of Adjuvant Therapy for Melanoma
    Cohen, Justine V.
    Buchbinder, Elizabeth I.
    CURRENT ONCOLOGY REPORTS, 2019, 21 (12)
  • [10] Update on adjuvant melanoma therapy
    Dimitriou, Florentia
    Braun, Ralph Peter
    Mangana, Joanna
    CURRENT OPINION IN ONCOLOGY, 2018, 30 (02) : 118 - 124
12345